These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9769507)

  • 1. [Erythrocyte, plasma and substitute hemoglobins facing physiological oxidizing and reducing agents].
    Faivre-Fiorina B; Caron A; Labrude P; Vigneron C
    Ann Biol Clin (Paris); 1998; 56(5):545-56. PubMed ID: 9769507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopreservation of red blood cells--the struggle with hemoglobin oxidation.
    Kanias T; Acker JP
    FEBS J; 2010 Jan; 277(2):343-56. PubMed ID: 19968714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components.
    Harrington JP; Gonzalez Y; Hirsch RE
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):477-92. PubMed ID: 11063090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxynitrite induces long-lived tyrosyl radical(s) in oxyhemoglobin of red blood cells through a reaction involving CO2 and a ferryl species.
    Minetti M; Scorza G; Pietraforte D
    Biochemistry; 1999 Feb; 38(7):2078-87. PubMed ID: 10026290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids as reductants of ferryl hemoglobin.
    Gebicka L; Banasiak E
    Acta Biochim Pol; 2009; 56(3):509-13. PubMed ID: 19774231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of recombinant hemoglobins for use in transfusion fluids.
    Fronticelli C; Koehler RC
    Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The involvement of nitric oxide in formation of hemoglobin oxygen-binding properties].
    Zinchuk VV
    Usp Fiziol Nauk; 2003; 34(2):33-45. PubMed ID: 12754789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins.
    Alayash AI; Ryan BA; Cashon RE
    Arch Biochem Biophys; 1998 Jan; 349(1):65-73. PubMed ID: 9439583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies of the oxidation of pyridoxalated hemoglobin polyoxyethylene conjugate by nitrogen monoxide.
    Herold S
    Arch Biochem Biophys; 1999 Dec; 372(2):393-8. PubMed ID: 10600181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the ascorbate-glutathione antioxidant system.
    Simoni J; Villanueva-Meyer J; Simoni G; Moeller JF; Wesson DE
    Artif Organs; 2009 Feb; 33(2):115-26. PubMed ID: 19178455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical mechanistic basis of oxidants of methaemoglobin formation.
    Akintonwa DA
    Med Hypotheses; 2000 Feb; 54(2):312-20. PubMed ID: 10790768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.
    Dorman SC; Kenny CF; Miller L; Hirsch RE; Harrington JP
    Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):39-51. PubMed ID: 12000225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular invertebrate hemoglobins as model therapeutic oxygen carriers: unique redox potentials.
    Harrington JP; Kobayashi S; Dorman SC; Zito SL; Hirsch RE
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):53-67. PubMed ID: 17364471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin oxidation products extract phospholipids from the membrane of human erythrocytes.
    Moxness MS; Brunauer LS; Huestis WH
    Biochemistry; 1996 Jun; 35(22):7181-7. PubMed ID: 8679546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of hemoglobin solutions as red cell substitutes.
    Ogden JE; Parry ES
    Int Anesthesiol Clin; 1995; 33(1):115-29. PubMed ID: 7635553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methemoglobin pathophysiology.
    Jaffé ER
    Prog Clin Biol Res; 1981; 51():133-51. PubMed ID: 7022466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin autooxidation/oxidation mechanisms and methemoglobin prevention or reduction processes in the bloodstream. Literature review and outline of autooxidation reaction.
    Faivre B; Menu P; Labrude P; Vigneron C
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):17-26. PubMed ID: 9507753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?
    Alayash AI
    Nat Biotechnol; 1999 Jun; 17(6):545-9. PubMed ID: 10385317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
    Eastman AL; Minei JP
    Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of bovine hemoglobin-loaded nanoparticles used as blood substitutes and establishment of reduction system].
    Zhang X; Yuan Y; Shan X; Sheng Y; Zhao J; Liu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1332-7. PubMed ID: 19166204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.